Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy
- PMID: 19780028
- DOI: 10.1002/jcp.21931
Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy
Abstract
Activation of nuclear factor kappaB (NF-kappaB) has been found necessary for cardiac hypertrophic growth in vivo and in vitro experiments. Adiponectin, an adipocyte-derived polypeptide, suppresses cardiac hypertrophy in response to pressure overload. Here we investigated the potential effect of adiponectin on NF-kappaB activation in hypertrophic neonatal rat ventricular myocytes (NRVMs) and related signal transduction pathway. We treated NRVMs with globular adiponectin (gAd) before angiotensin II (AngII) stimulation. Pretreating cells with gAd reduced the increased incorporation of [(3)H]-leucine and the mRNA levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) stimulated by AngII, indicating gAd inhibited AngII-induced cardiac hypertrophic signaling. Moreover, gAd pretreatment suppressed inhibitory protein kappaB (I-kappaB) phosphorylation and decreased p65 nuclear translocation, DNA-binding and transcription activity of NF-kappaB. Meanwhile, gAd promoted AMP-activated protein kinase (AMPK) phosphorylation, which is a downstream signaling mediator of adiponectin. Pharmacological activator of AMPK could inhibit AngII-induced NF-kappaB translocation, and inhibitor of AMPK or a dominant-negative AMPK adenovirus suppressed gAd-mediated inhibition of I-kappaB phosphorylation and NF-kappaB activation. When AMPK was inhibited, the suppressive effect of gAd on ANP mRNA expression was reduced. Our data indicate that gAd inhibits cardiac hypertrophic signaling through AMPK mediated suppression of NF-kappaB activation.
Similar articles
-
Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.J Cell Biochem. 2007 Apr 1;100(5):1086-99. doi: 10.1002/jcb.21197. J Cell Biochem. 2007. PMID: 17266062
-
Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes.Regul Pept. 2007 Mar 1;139(1-3):72-9. doi: 10.1016/j.regpep.2006.10.007. Epub 2006 Nov 15. Regul Pept. 2007. PMID: 17109977
-
Globular adiponectin activates nuclear factor-kappaB and activating protein-1 and enhances angiotensin II-induced proliferation in cardiac fibroblasts.Diabetes. 2007 Mar;56(3):804-8. doi: 10.2337/db06-1405. Diabetes. 2007. PMID: 17327451
-
Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.Can J Physiol Pharmacol. 2005 Jan;83(1):24-8. doi: 10.1139/y04-107. Can J Physiol Pharmacol. 2005. PMID: 15759047 Review.
-
Regulating the regulator: NF-kappaB signaling in heart.J Mol Cell Cardiol. 2006 Oct;41(4):580-91. doi: 10.1016/j.yjmcc.2006.07.006. Epub 2006 Sep 1. J Mol Cell Cardiol. 2006. PMID: 16949095 Review.
Cited by
-
A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease.Clin Kidney J. 2019 Sep 18;12(6):861-870. doi: 10.1093/ckj/sfz106. eCollection 2019 Dec. Clin Kidney J. 2019. PMID: 31807301 Free PMC article.
-
AMPK: a balancer of the renin-angiotensin system.Biosci Rep. 2019 Sep 3;39(9):BSR20181994. doi: 10.1042/BSR20181994. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31413168 Free PMC article. Review.
-
The cardio-protective signaling and mechanisms of adiponectin.Am J Cardiovasc Dis. 2012;2(4):253-66. Epub 2012 Oct 20. Am J Cardiovasc Dis. 2012. PMID: 23173099 Free PMC article.
-
Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H984-93. doi: 10.1152/ajpheart.00428.2011. Epub 2011 Jun 10. Am J Physiol Heart Circ Physiol. 2011. PMID: 21666115 Free PMC article.
-
The role of adiponectin signaling in metabolic syndrome and cancer.Rev Endocr Metab Disord. 2014 Jun;15(2):157-67. doi: 10.1007/s11154-013-9265-5. Rev Endocr Metab Disord. 2014. PMID: 24019064 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources